Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2019, Article ID 5647940, 5 pages
https://doi.org/10.1155/2019/5647940
Case Report

Increasing Evidence for the Association of Breast Implant-Associated Anaplastic Large Cell Lymphoma and Li Fraumeni Syndrome

1Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, LS7 4SA, UK
2Department of Haematology, St James’s University Hospital, Leeds, LS9 7TF, UK
3Department of Breast and Endocrine Surgery, St James’s University Hospital, Leeds, LS9 7TF, UK

Correspondence should be addressed to Julian Adlard; ten.shn@dralda.j

Received 19 May 2019; Accepted 7 July 2019; Published 16 July 2019

Academic Editor: Christos Yapijakis

Copyright © 2019 Julian Adlard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. Quesada, L. J. Medeiros, M. W. Clemens et al., “Breast implant-associated anaplastic large cell lymphoma: a review,” Modern Pathology, vol. 32, no. 2, pp. 166–188, 2019. View at Publisher · View at Google Scholar
  2. S. H. Swerdlow, E. Campo, S. A. Pileri et al., “The 2016 revision of the World Health Organization classification of lymphoid neoplasms,” Blood, vol. 127, no. 20, pp. 2375–2390, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. D. J. Collett, H. Rakhorst, P. Lennox, M. Magnusson, R. Cooter, and A. K. Deva, “Current risk estimate of breast implant–associated anaplastic large cell lymphoma in textured breast implants,” Plastic and Reconstructive Surgery, vol. 143, no. S3, pp. 30S–40S, 2019. View at Publisher · View at Google Scholar
  4. M. W. Clemens, E. D. Jacobsen, and S. M. Horwitz, “2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL),” Aesthetic Surgery Journal, vol. 39, no. Supplement 1, pp. S3–S13, 2019. View at Publisher · View at Google Scholar
  5. C. Ratignier-Carbonnei, “ANSM decides, as a precautionary measure, to withdraw from the market macrotextured breast implants and breast implants with polyurethane-coated surfaces - ANSM does not recommend preventive explantation for women carrying these implants,” ANSM Communiqué, April 2019. View at Google Scholar
  6. T. Guha and D. Malkin, “Inherited TP53 mutations and the Li–Fraumeni syndrome,” Cold Spring Harbor Perspectives in Medicine, vol. 7, no. 4, Article ID a026187, 2017. View at Publisher · View at Google Scholar
  7. K. C. de Andrade, M. N. Frone, T. Wegman-Ostrosky et al., “Variable population prevalence estimates of germline TP53 variants: a gnomAD-based analysis,” Human Mutation, vol. 40, no. 1, pp. 97–105, 2019. View at Publisher · View at Google Scholar
  8. C. P. Kratz, M. I. Achatz, L. Brugières et al., “Cancer screening recommendations for individuals with Li-fraumeni syndrome,” Clinical Cancer Research, vol. 23, no. 11, pp. e38–e45, 2017. View at Publisher · View at Google Scholar
  9. Y. Lee, A. Filie, D. Arthur, A. T. Fojo, and E. S. Jaffe, “Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome,” Histopathology, vol. 67, no. 6, pp. 925–927, 2015. View at Publisher · View at Google Scholar
  10. R. G. Pastorello, F. D’Almeida Costa, C. A. Osório et al., “Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report,” Diagnostic Pathology, vol. 13, no. 1, p. 10, 2018. View at Publisher · View at Google Scholar
  11. P. Blombery, E. Thompson, G. L. Ryland et al., “Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma,” Oncotarget, vol. 9, no. 90, pp. 36126–36136, 2018. View at Publisher · View at Google Scholar
  12. H. Hu, K. Johani, A. Almatroudi et al., “Bacterial biofilm infection detected in breast implant–associated anaplastic large-cell lymphoma,” Plastic and Reconstructive Surgery, vol. 137, no. 6, pp. 1659–1669, 2016. View at Publisher · View at Google Scholar
  13. A. Di Napoli, P. Jain, E. Duranti et al., “Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A,” British Journal of Haematology, vol. 180, no. 5, pp. 741–744, 2018. View at Publisher · View at Google Scholar
  14. H. Wang, C. Xie, S. Li et al., “Dysregulation, but not mutation of p53 signaling pathway in breast implant-associated anaplastic large cell lymphoma cell lines,” Blood, vol. 122, p. 4879, 2013. View at Google Scholar
  15. L. A. Donehower, M. Harvey, B. L. Slagle et al., “Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours,” Nature, vol. 356, no. 6366, pp. 215–221, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Inoue and E. A. Fry, “Haploinsufficient tumor suppressor genes,” Advances in Medicine and Biology, vol. 118, no. 1, pp. 83–122, 2017. View at Google Scholar · View at Scopus
  17. R. A. Wilcox, “Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOP,” The Lancet Haematology, vol. 5, no. 5, pp. e182–e183, 2018. View at Publisher · View at Google Scholar